Half Year 2025 Tecan Group AG Earnings Call Transcript
Key Points
- Tecan Group AG (TCHBF) reported CHF439 million in revenue for H1 2025, with an adjusted EBITDA of CHF65.7 million and a margin of 15%, aligning with expectations.
- The Life Sciences business returned to growth in local currencies, driven by strong uptake in consumables, particularly in genomic testing labs.
- The company achieved solid sales growth in Synergence in vitro diagnostic systems, and Cavro saw substantial order entry growth in Q2.
- Operational resilience was enhanced through a comprehensive cost reduction program and site consolidation, optimizing supply chain and increasing vertical integration.
- Tecan Group AG (TCHBF) launched innovative products like the multiomics Veya workstation and Duo Digital Dispenser, which received strong customer interest.
- Overall sales in China declined as expected, with subdued demand and delays in government tenders impacting performance.
- The Partnering Business experienced a 7% lower growth, with the Paramit line declining as anticipated.
- Order entry for the first six months was down 2.9% year on year, reflecting a challenging market environment.
- Reported net profit decreased to CHF17.9 million from CHF22.5 million in the first half of 2024, impacted by lower operating profit and negative currency effects.
- The effective tax rate increased to 22.5% from 20.5% last year, further weighing down net profit.
Good morning, everyone. Thank you for joining our conference call this morning. We are pleased to share and discuss our results for the first half of 2025 with you.
Joining me on the call today are our Chief Executive Officer, Monica Manotas; and our Chief Financial Officer, Tania Micki. Before we begin, let me quickly cover a few formalities.
The press release announcing our financial results was issued this morning at 6:00 AM Central European Summer Time. Both the press release and the 2025 interim report are available on our website, tecan.com, under the Investor Relations section. I'd also like to remind you that this call is being webcast live on our homepage, and the PDF of the presentation slides we'll be discussing is available for download as well.
Let's take a quick look at today's agenda. First, Monica will provide a brief introduction and discuss key market trends and their impact on our two business segments. She'll then share some background on our operating
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
